Navigation Links
Alexza Reports 2010 Fourth Quarter and Full Year Financial Results and Provides General Corporate Update
Date:3/15/2011

meeting in January 2011.  Alexza anticipates resubmitting its AZ-004 NDA in July 2011.
  • Alexza announced that the British Journal of Psychiatry, a publication of the Royal College of Psychiatrists, published the results of the pivotal Phase 3 study evaluating AZ-004 (inhaled or Staccato loxapine) for the rapid treatment of agitation in patients with schizophrenia, in its January 2011 edition (198:51-58).
  • Alexza received notice that AZ-004 is eligible for submission of a Marketing Authorization Application (MAA) under the centralized registration procedure.  Alexza has been notified of the Rapporteur and co-Rapporteur appointments for the AZ-004 review.  The Company believes that the comprehensive clinical development program for AZ-004 meets the requirements for the MAA filing and expects to submit the MAA in Q3 2011.

  • Financial Results - Periods Ended December 31, 2010 and 2009

    Alexza recorded $42.1 million and $42.9 million of revenues in the quarter and year ended December 31, 2010, and $9.5 million in the year ended December 31, 2009.  The Company recorded no revenues during the quarter ended December 31, 2009.  In October 2010, Biovail terminated the license and supply agreement for AZ-004, at which time Alexza recognized as revenue the $40 million non refundable up-front payment received in February 2010.  In September 2010, the Company began to recognize revenues related to payments received from Cypress Biosciences, Inc. as part of the license agreement signed in August 2010, resulting in revenues of $1.9 million and $2.6 million for the quarter and year ended December 31, 2010, respectively.  In January 2009, Alexza and Endo Pharmaceuticals mutually agreed to terminate their development agreement related to AZ-003 (Staccato fentanyl), at which time Alexza had fulfilled its obligations under the development agreement and recognized $9.5 million in revenues.

    GAAP
    '/>"/>

    SOURCE Alexza Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8

    Related medicine technology :

    1. Alexza to Announce 2010 Year-End Financial Results on Tuesday, March 15, 2011
    2. Alexza Pharmaceuticals Completes End-of-Review Meeting With FDA for AZ-004 (Staccato® Loxapine) NDA
    3. Alexza Pharmaceuticals Provides Regulatory Update for AZ-004 (Staccato® Loxapine)
    4. Alexza Pharmaceuticals Reports 2010 Third Quarter Financial Results and Provides Business Update
    5. Alexza Pharmaceuticals to Announce 2010 Third Quarter Financial Results on November 9, 2010
    6. Alexza Pharmaceuticals Reacquires U.S. and Canadian Rights for AZ-004 (Staccato® Loxapine)
    7. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
    8. Alexza Pharmaceuticals Receives Complete Response Letter for AZ-004 (Staccato® Loxapine) NDA
    9. Alexzas Staccato® Nicotine Licensed to Cypress Bioscience
    10. Alexza Pharmaceuticals to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference
    11. Alexza Pharmaceuticals Appoints Joseph L. Turner to Its Board of Directors
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/17/2014)... 17, 2014 Prostate Oncology Specialists announces ... to educate men about new imaging technology destined ... prostate. Annually, a million men undergo random needle ... MRI (MP-MRI) of the prostate gland is non-invasive ... need to be fully informed of their alternatives. ...
    (Date:9/17/2014)...  Rebiotix Inc. announced this morning that results of the ... (microbiota suspension) will be presented in two posters and a ... Philadelphia from October 8-12. PUNCH ... on Thursday, October 9, 2014: Poster: RBX2660 (microbiota ... Analysis of the PUNCH-CD Phase 2 Safety Study ...
    (Date:9/17/2014)... and SAN JOSE, Calif. , ... has been named as a laureate of The Tech Awards ... applying technology to benefit humanity and spark global change. The ... Innovation, and presented by Applied Materials, Inc., selected Gradian as ... Photo - http://photos.prnewswire.com/prnh/20140917/146680 ...
    Breaking Medicine Technology:Prostate Cancer Awareness Month - Stop Random Biopsies 2Prostate Cancer Awareness Month - Stop Random Biopsies 3PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 2PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 3PUNCH CD Study Drug Targeting Recurrent C. difficile Infection to be Presented at IDWeek 2014 4Gradian Health Systems Named A 2014 Laureate of The Tech Awards 2Gradian Health Systems Named A 2014 Laureate of The Tech Awards 3
    (Date:9/17/2014)... (PRWEB) September 17, 2014 Final Cut Pro ... entitled ProBlue 5k from Pixel Film Studios. , “ProBlue 5k ... users video from good to epic,” said Christina Austin, CEO ... armature, ProBlue 5k is a definite game changer.” , ProBlue ... package for any filmmaker ! This footage compilation of ...
    (Date:9/17/2014)... 2014 People who struggle to distinguish between ... http://www.perwickstrom.com and get the answer by reading Per ... out, is that a business plan and a business strategy ... commented Per Wickstrom. “The way I view it is that ... strategy which is part two.” , According to the ...
    (Date:9/17/2014)... IL (PRWEB) September 17, 2014 The ... Pseudomonas aeruginosa infections allegedly caused by Non-Sterile Other-Sonic ... learn more about their options for legal recourse. Other-Sonic ... Drug Administration (FDA) in March 2012, after the product ... aeruginosa at William Beaumont Hospital in Royal Oak, Michigan ...
    (Date:9/17/2014)... Dennis Thompson HealthDay Reporter ... in the womb to household chemicals known as phthalates ... Columbia University researchers reported in a new study. ... developing asthma between age 5 and 11 if their ... two phthalates (pronounced thal-ates), the researchers found. The two ...
    (Date:9/17/2014)... FRISCO, Texas (PRWEB) September 17, 2014 ... (EV-D68) outbreak that is hospitalizing scores of infants, children ... Louisiana, says Dr. Kirk Mahon, medical director of Legacy ... , “There have been no reported cases of EV-D68 ... Oklahoma and Louisiana, that could change,” he said. “Implementing ...
    Breaking Medicine News(10 mins):Health News:A New Plugin Entitled ProBlue 5k Was Released Today from Pixel Film Studios Exclusively for Final Cut Pro X 2Health News:Per Wickstrom’s Latest Blog Explores the Difference Between a Business Plan and a Business Strategy 2Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 2Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 3Health News:Victims of Pseudomonas Infections Allegedly Caused by Other-Sonic Ultrasound Transmission Gel Face Statute of Limitations, Reports The Oliver Law Group P.C. 4Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 2Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 3Health News:Prenatal Exposure to Chemicals in Plastics Linked to Asthma Risk in Kids 4Health News:Legacy ER & Urgent Care Warns North Texans about Dangers of Enterovirus D68 2
    ... 17 (HealthDay News) -- Among long-term breast cancer survivors, those ... much higher rates of death due to heart disease, new ... Jan. 25 issue of the Journal of the American ... such as that practiced until the mid-1980s, increased the long-term ...
    ... birth weight in First Nations (North American Indian) babies are ... that occur from 4 weeks to 1 year of age), ... Canadian Medical Association Journal ) (pre-embargo link only) http://www.cmaj.ca/embargo/cmaj100837.pdf ... as a child being born above the 90th percentile relative ...
    ... By Steven Reinberg HealthDay Reporter , ... are taking common blood pressure medications called calcium channel ... blood pressure and possibly going into shock if they ... antibiotics, erythromycin and clarithromycin, if given to patients taking ...
    ... on the milk we drink, according to new research ... during a particularly poor UK summer and the following ... less beneficial fatty acids than in a more ,normal, ... organic milk could help overcome these problems. Organic ...
    ... HealthDay Reporter , SATURDAY, Jan. 15 (HealthDay News) -- ... the breathing tube that had been in place since she ... attack in Tucson that killed six people. The new ... the Associated Press . The breathing tube had been ...
    ... January 14, 2011The ongoing controversy about the appropriate ... be explored at the upcoming 19th Annual Congress ... DC. A provocative "Point-Counterpoint: The Mammography Controversy" will ... PhD, Visiting Professor of Radiology, Magee-Womens Hospital, University ...
    Cached Medicine News:Health News:Breast Cancer Radiation Before 1984 Tied to Heart Disease 2Health News:High birth weight in First Nations babies linked to a higher risk of postneonatal death 2Health News:Some Antibiotics, Blood Pressure Meds a Bad Mix: Study 2Health News:Some Antibiotics, Blood Pressure Meds a Bad Mix: Study 3Health News:Choosing organic milk could offset effects of climate change 2Health News:Choosing organic milk could offset effects of climate change 3Health News:Choosing organic milk could offset effects of climate change 4Health News:Rep. Giffords Has Surgery to Replace Breathing Tube 2Health News:Rep. Giffords Has Surgery to Replace Breathing Tube 3Health News:Mammography controversy to be explored at 19th Annual Congress on Women's Health 2
    For the quantitative in vitro determination of Microalbumin in urine....
    Determination of the Thrombin Time by STA Analyzers. Freeze-dried human thrombin (1.5NIH units/mL) with calcium....
    Determination of Activated Partial Thromboplastin Time (APTT) by STA Analyzers. Cephalin reagent with kaolin activator....
    Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
    Medicine Products: